#biofragmentive | Explore Tumblr posts and blogs

healthcare00897 · 6 years ago

Text

Nasal Packing Devices Market is forecasted to witness a thriving growth by 2026

Nasal packing device are intranasal devices that exert constant local pressure to the nasal septum, indicated for epistaxis, also known as nosebleed. Epistaxis occurs due to rupturing of a small blood vessel in the nose lining. Interior of the nose is delicate and highly sensitive to certain factors that make them fragile and prone to burst resulting in bleeding. There are two types of epistaxis anterior and posterior, which requires different type as nasal packing devices. The posterior nasal packing is indicated for failure of anterior packing, reliable or high suspicion of posterior bleeding, patient with bleeding diathesis, which include antiplatelet therapy von Willebrand disease (vWD), anticoagulation, and hemophilia. Whereas, anterior nasal packing is indicated when no source can be identified or cautery has failed.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1332

Nasal packing is a second-line therapy for epistaxis. It is accomplished with gauze, a Foley catheter, inflatable nasal balloon catheter or a nasal sponge/tampon, topical anesthesia and vasoconstriction, injectable, gels and spray, which stops nose bleeding. According to an article published by Life in the Fast Lane in 2011, nosebleeds commonly occur between the ages of 2-10 and 50-80 years, out of which the 50-80 contributes a major part. Thus, increasing number of geriatric population is also responsible for boosting growth of the global nasal packing devices market.

Increasing prevalence of epistaxis is expected to boost growth of the nasal packing devices market

According to a research article published in International Journal of Otolaryngology in 2015, epistaxis is estimated to affect around 10-12% of the total world population, out of which around 80% patients require medical attention as majority of epistaxis cases are not self-limiting and cannot be resolved due to intervention. Increasing number of nosebleeds cases are expected to foster growth of the nasal packaging device market. Epistaxis is a commonly encountered clinical condition that results in uncertain nose bleeding from either of the nostrils. The most common cause for epitaxies is hypertension. Cardiovascular disorders lead to hypertension, which in turn is favoring growth of the nasal packaging device market. According to the Medical Statistics of World Health Organization (WHO) in 2015, an estimated 289,000 cases of hypertension were reported among pregnant women. According to the American Pregnancy Organization, the circulatory system expands during pregnancy so as to accommodate the baby. The expansion leads to increase in creation and circulation of blood that may lead to problematic issues and frequent nosebleeds during pregnancy. Thus, increasing number of pregnant women suffering from hypertensive diseases is expected to boost growth of the global nasal packing devices market over the forecast period. Moreover, increasing number of patients suffering from nasal tumors benign or malignant also contributes to the nasal packing devices market.

Nasal Packing Devices Market Taxonomy

By Product Type:

Injectable

Gel

Spray

Dressings

Sponges

Splints

Strips

By Material:

Bio-resorbable

Chitosan

HYAFF

Combination

Non-absorbable

CMC

Synthetic

Others

By End User:

Hospitals & Nursing Homes

Clinics

Ambulatory Surgical Centers

Home Care Settings

Other

North America dominates the nasal packing devices market

On the basis of regional segmentation, the global nasal packing devices market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account for the largest share, followed by Europe and Asia Pacific. Nasal packing devices market in North America is driven by new product launches and technological advancement. For instance, in 2014, Medtronic launched the NovaShield injectable and biofragmentable nasal packing stent, which is designed to decrease post-operative bleeding and prevent adhesions in nasal structures in patients, who undergo functional endoscopic sinus surgery (FESS). Whereas, according to Medtronic, around 525,000 FESS procedures are performed in the U.S. annually.

The nasal packaging market in Asia Pacific is emerging due to increasing number of geriatric population and rapid technological development in the healthcare sector, which is fueling growth of the market. According to the United Nations Population Fund, the number of older people in the Asia Pacific region is increasing at an unprecedented rate and it is at the forefront of the global phenomenon of population ageing. By 2050, one in four people in Asia and the Pacific are expected to be over 60 years old. The population of older persons (aged over 60) in the Asia Pacific region will triple between 2010 and 2050, reaching close to 1.3 billion people, favoring the growth of nasal packaging device market in Asia Pacific region.

The key players dominating the global nasal packing devices market

Key players are involved in research and development for technological advancements and innovation of nasal packaging devices. For instance, in 2016, Smith & Nephew launched a range of nasal packaging devices with RAPID RHINO technology, which has a blend of carboxymethylcellulose (CMC) exhibiting self-lubricating properties that provide gentle and even compression to the nasal area and helps in quick re-conformation of the nasal anatomy. Various similar technological advancements and strategic implementations by emerging and established market players are expected to foster growth of the global nasal packaging device market.

The key players operating in the global nasal packing devices market include Medtronic plc, Stryker Corporation, Smith & Nephew, Inc., Summit Medical Group, Lohmann & Rauscher GmbH & Co.KG, Entellus Medical, Inc., Olympus Corporation, and Network Medical Products Ltd.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/nasal-packing-devices-market-1332

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: [email protected]

0 notes

rohinic123-blog · 5 years ago

Text

Epistaxis Devices Market to Observe Strong Development by 2027

Epistaxis is a condition that results in uncertain nose bleeding from either of the nostrils. This clinical condition is usually classified as posterior epistaxis and anterior epistaxis based on the site where the bleeding originates. According to The New England Journal of Medicine, around 60% of people worldwide have faced epistaxis at least once during their lifetime, and out of these, 6% patients required medical treatment. The prevalence of Epistaxis is high in children less than 10 years of age and people over the age of 35 years.

Report Overview @

https://www.transparencymarketresearch.com/epistaxis-devices-market.html

Epistaxis is usually caused by local trauma, including nasal infection and even nose picking. Environmental factors causing epistaxis include lack of humidity in the atmosphere, dry climate, or prolonged inhalation of dry air. People who are on medications such as clopidogrel, warfarin, aspirin, or any other anticoagulant medications are more susceptible to epistaxis. Other predisposing factors such as, cocaine snorting, allergic and non-allergic rhinitis, alcohol abuse, hypertension, and inherited bleeding problems also lead to epistaxis. Epistaxis Devices are used in the treatment of nosebleed. Epistaxis devices includes nasal tampons, nasal catheters and others

Planning To Lay Down Future Strategy? Request Brochure Of Epistaxis Devices Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=72312

Global Epistaxis Devices Market: Competitive Landscape

Major players have adopted strategies such as partnerships, agreements, new product development, and collaborations to gain competitive advantage in the global epistaxis devices market.

In 2016, Smith & Nephew launched a range of epistaxis devices with RAPID RHINO technology that has blend of carboxymethylcellulose

Teleflex Incorporated

Founded in 1943, Teleflex Corporation is based in Wayne, New Jersey, U.S. The company has a diverse product portfolio with solutions in fields such as interventional access, vascular access, cardiology, anesthesia, surgical care, respiratory care, and emergency services. It provides epistaxis devices such as epistaxis catheters to offer rapid and effective control of nasal bleeding.

Medtronic Plc

Established in 1949, Medtronic is based in Minneapolis, U.S. The company operates through four main business segments: Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group and Diabetes Group. Medtronic operates in 160 countries across 480 locations globally, serving more than 65 million patients. It holds more than 45,000 patents in the medical technology industry. Medtronic offers nasal packaging products including bioresorbable and biofragmentable nasal packing, which help control bleeding and heal wounds.

To Obtain All-Inclusive Information On Forecast Analysis Of Epistaxis Devices Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=72312

Smith & Nephew plc

Founded in 1856, Smith & Nephew plc engages in the development, manufacture, and sale of medical devices for advanced surgeries and wound care management. The company distributes its products in more than 90 countries across Europe, North America, Asia Pacific, and Middle East & Africa. The company has a broad product portfolio for treatment of epistaxis.

Stryker

Founded in 1941, Stryker Corporation (Stryker) is a medical technology company which offers a diverse array of innovative products and services in orthopedics, medical and surgical, neurotechnology, and spine products. Stryker operates in the U.S., EMEA, Asia Pacific, Canada, and Latin America. Stryker provides a wide range of products for the treatment of epistaxis including bioresorbable and dissolvable nasal packing products such as XeroGel, NasoPore, and HemoPore.

Request For Covid19 Impact Analysis –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=72312

Global Epistaxis Devices Market: Dynamics

Increasing Prevalence of Hypertension and Change in Environment to Boost Market

Hypertension is highly susceptible to hemorrhage are leading causes of epistaxis. According to Center for Disease Control and Prevention (CDC), high blood pressure happens in 1 in every 12 to 17 pregnancies among women ages 20 to 44. Furthermore, air pollution is a major factor which is likely to cause epistaxis. Breathing polluted air is more prone to cause epistaxis. According to World Economic Forum, more than 9 out of 10 people breathe polluted air. All these factors are likely to boost the global epistaxis devices market.

Focus on Launch of Innovative Products to Boost Epistaxis Devices Market

Manufacturers operating in the epistaxis devices market are strongly focusing on increasing investments in research & development activities to design and develop new and innovative epistaxis devices. For instance, Stryker has an innovative product, XeroGel, which is a unique blend of polyethylene glycol (PEG) and chitosan, for a comfortable post-operative experience for patients.

More Trending Reports by Transparency Market Research –

Viral Vector & Plasmid DNA Manufacturing Market –

https://www.prnewswire.com/news-releases/global-viral-vector--plasmid-dna-manufacturing-market-to-chart-23-3-cagr-from-2019-to-2027-transparency-market-research-301000176.html

Read our Case study at

https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

0 notes